GH Receptor Antagonist: Mechanism of Action and Clinical Utility

ISSN： 1389-9155

Source： Reviews in Endocrine and Metabolic Disorders, Vol.6, Iss.1, 2005-01, pp. : 5-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanism of Cholecystokinin-A- Receptor Antagonist on Human Pancreatic Exocrine Secretion

Digestion, Vol. 60, Iss. 1, 1999-03 ,pp. : 75-80

Karger

Access to resources Recommend Favorite

Clinical use of a growth hormone receptor antagonist in the treatment of acromegaly

By Drake W.M. Parkinson C. Besser G.M. Trainer P.J.

Trends in Endocrinology and Metabolism, Vol. 12, Iss. 9, 2001-11 ,pp. : 408-413

Elsevier

Access to resources Recommend Favorite

Clinical Evaluation of Cholecystokinin-A- Receptor Antagonist (Loxiglumide) for the Treatment of Acute Pancreatitis

Digestion, Vol. 60, Iss. 1, 1999-03 ,pp. : 81-85

Karger

Access to resources Recommend Favorite

Pacing Postconditioning: Recent Insights of Mechanism of Action and Probable Future Clinical Application

Medical Principles and Practice, Vol. 25, Iss. 1, 2015-05 ,pp. : 22-28

Karger

Access to resources Recommend Favorite

Interleukin-1 receptor antagonist gene (IL-1RN) polymorphism is a predictive factor of clinical pregnancy after IVF

By Gremlich S. Fratta S. Rebellato E. Uras R. Reymondin D. Damnon F. Germond M. Gerber S.

Human Reproduction, Vol. 23, Iss. 5, 2008-05 ,pp. : 1200-1206

Oxford University Press

Access to resources Recommend Favorite